Data as of Apr 17
| +0.0499 / +4.12%|
The 2 analysts offering 12-month price forecasts for CounterPath Corp have a median target of 1.41, with a high estimate of 1.57 and a low estimate of 1.25. The median estimate represents a +11.74% increase from the last price of 1.26.
The current consensus among 2 polled investment analysts is to Hold stock in CounterPath Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.